Aristidis Tsatsakis#
Membership Number: | 6599 |
Membership type: | ORDINARY |
Section: | CLINICAL & VETERINARY SCIENCE |
Affiliated section(s): | PHYSIOLOGY & NEUROSCIENCE |
Elected: | 2023 |
Main Country of Residence: | GREECE |
Homepage(s): | http://www.aristsatsakis.com/ |
ORCID: | 0000-0003-3824-2462 |
Facebook: | https://www.facebook.com/aristidis.tsatsakis |
Linkedin: | https://www.linkedin.com/in/aristidis-tsatsakis-37016a42/ |
Present and Previous Positions
- 2010 - present Professor of Toxicology, School of Medicine, University of Crete and University General Hospital, Greece
- 2001 - present Director of the Toxicology and the Forensic Science Department, School of Medicine, University of Crete and University General Hospital, Greece
- 2001 - 2010 Associate Professor, Department of Forensic Sciences, University of Crete and University General Hospital
- 2001 - 2005 Executive Board Member of the School of Medicine School of Medicine, University of Crete and University General Hospital, Greece
- 2001 - 2005 Director Division of Morphology, School of Medicine, University of Crete and University General Hospital
- 1996 - 2001 Tenure Assistant Professor of Toxicology, Department of Forensic Sciences, University of Crete and University General Hospital
- 1993 - 1996 Assistant Professor of Toxicology, Department of Forensic Sciences, University General Hospital
- 1996 Visiting Research Fellow, University of Florida and Schands Hospital, USA
- 1994 Research Fellow, Toxicology Centre, University of Antwerp, Belgium
- 1988 - 1993 Lecturer, Head of Toxicology Unit of Department of Forensic Sciences, School of Medicine, University of Crete and University General Hospital
- 1992 Research Fellow University of Maryland and O.C.M.E Baltimore, USA
- 1986 - 1989 Adjunct Assistant Professor, Department of Chemistry, University of Crete
- 1987 - 1990 Post-doctoral Fellow, Macromolecular Chemistry, Mendeleyev University
Fields of Scholarship
- Development of analytical methods for testing of drugs and xenobiotics.
- Human biomonitoring, monitoring and biomonitoring of xenobiotics in the ecosystem
- Real life risk simulation of exposure
- Telomeres length, chronic diseases and aging. Focus on biomarkers and modulation of telomerase
- Development of macromolecular and nano systems for targeting and reducing toxicity of drugs
- Chronic exposure to xenobiotics and impact on human health and linking to diseases
- Forensic and clinical issues of anabolic and drugs of abuse
- Nanomedicine, nanotoxicology
Honours and Awards
- 2022 EUROTOX Merit Award 2022
- 2021 Highly Cited Researcher 2021, Clarivate Analytics – Web of Science
- 2021 Commemorative medal “130 years of the Federal Scientific Center of Hygiene named after F.F.Erisman”
- 2020 Higly Cited Researcher, Clarivate Analytica – Web of Science (2020)
- 2017 Merit Award Greek Ministry of Agriculture (2017)
- 2016 Award of Excellence, MED Solutions, International group
- 2016 Merit Award BIONANOTOX Symposiums
- 2001 Gold Metal, Eminent Scientist, Int.Research Promotion Council (IRPC)